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Imaging mass spectrometry (IMS) has transformed proteomics
by providing an avenue for collecting spatially distributed molecu-
lar data. Mass spectrometry data acquired with matrix assisted laser
desorption ionization (MALDI) IMS consist of tens of thousands of
spectra, measured at regular grid points across the surface of a tissue
section. Unlike the more standard liquid chromatography mass spec-
trometry, MALDI-IMS preserves the spatial information inherent in
the tissue.
Motivated by the need to differentiate cell populations and tissue
types in MALDI-IMS data accurately and efficiently, we propose an
integrated cluster and feature extraction approach for such data. We
work with the derived binary data representing presence/absence of
ions, as this is the essential information in the data. Our approach
takes advantage of the spatial structure of the data in a noise removal
and initial dimension reduction step and applies k-means clustering
with the cosine distance to the high-dimensional binary data. The
combined smoothing-clustering yields spatially localized clusters that
clearly show the correspondence with cancer and various noncancer-
ous tissue types.
Feature extraction of the high-dimensional binary data is accom-
plished with our difference in proportions of occurrence (DIPPS) ap-
proach which ranks the variables and selects a set of variables in
a data-driven manner. We summarize the best variables in a single
image that has a natural interpretation. Application of our method
to data from patients with ovarian cancer shows good separation of
tissue types and close agreement of our results with tissue types iden-
tified by pathologists.
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1. Introduction. Mass spectrometry (MS) has become a versatile and
powerful tool in proteomics for the analysis of complex biological systems,
including the identification and quantification of proteins and peptides [Ong
and Mann (2005)]. Many different technologies have been developed under
the collective field of proteomics mass spectrometry [Aebersold and Mann
(2003)]. The focus in this paper is the more recent development [see Grose-
close et al. (2006), Aoki et al. (2007)] of matrix assisted laser desorption ion-
ization (MALDI) imaging mass spectrometry (IMS), also known as MALDI
imaging, and, in particular, an analysis of MALDI-IMS data acquired from
tissue samples of patients with ovarian cancer.
Unlike the more common 2D gel electrophoresis (2D-GE) and liquid chro-
matography (LC) based techniques in proteomics, MALDI-IMS preserves
the spatial distribution inherent in the tissue; and the tens of thousands
of spatially distributed spectra acquired from a single tissue sample in a
MALDI-IMS experiment provide new challenges for statisticians and bioin-
formaticians as well as having the potential to lead to breakthroughs in
biological research [see Casadonte and Caprioli (2011)]. We propose a com-
bined cluster and feature extraction method for such data which exhibits
cancer-specific variables whose protein associations can be inferred by par-
allel LC-MS experiments such as those of Meding et al. (2012).
Standard proteomics mass spectrometry methods such as 2D-GE and LC-
MS have been described in the literature for some time; see Wasinger et al.
(1995). We briefly explain LC-MS and important differences with MALDI-
IMS in Section 2. For an overview and review of recent approaches in LC-
MS, see America and Cordewener (2008). Statistical challenges of proteomics
mass spectrometry data are outlined in Wu et al. (2003). The statistics and
bioinformatics literature on the analysis of 2D-GE and LC-MS data is grow-
ing fast and covers a range of statistical methods. Testing and classification
of such data are described in Morris et al. (2005), Morris (2012), Yu et al.
(2006) and references therein. Other statistical approaches that have been
proposed and applied to 2D-GE and LC-MS data include peak identifica-
tion, alignment and feature selection [see Yu et al. (2006)], identification of
proteins [see Yu et al. (2006) and Karpievitch et al. (2010)], wavelet-based
methods [see Morris and Carroll (2006), America and Cordewener (2008),
Du, Kibbe and Lin (2006) and references therein] and methods from sur-
vival analysis for the detection of differentially expressed proteins [see Tekwe,
Carroll and Dabney (2012)].
Contrasting these developments in the analyses of 2D-GE and LC-MS
data, the newer MALDI-IMS methods which have been introduced into rou-
tine research practice have not yet attracted as much attention in the statis-
tics literature, although MALDI-IMS methods are covered in proteomics/
mass spectrometry journals—see Alexandrov and Kobarg (2011), Alexan-
drov et al. (2010, 2013), Norris et al. (2007), Jones et al. (2012), Gessel,
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Norris and Caprioli (2014), Stone et al. (2012) and references therein. The
potential of MALDI-IMS is described in Alexandrov and Kobarg (2011):
“IMS is one of the most promising innovative measurement techniques in
biochemistry which has proven its potential in discovery of new drugs and
cancer biomarkers. . . . IMS was used in numerous studies leading to under-
standing chemical composition and biological processes. . . . As for many mod-
ern biochemical techniques, in particular in proteomics, the development of
computational methods for IMS is lagging behind the technological progress.”
In addition to presenting our approach and analyses of MALDI-IMS data,
we hope to motivate other statisticians and bioinformaticians to explore this
exciting and promising new area and to develop novel statistical methods
for the analysis of such data.
Related to our research are the papers by Deininger et al. (2008), Alexan-
drov et al. (2010) and Bonnel et al. (2011) who cluster their MALDI-
IMS data using principal component analysis and hierarchical clustering,
or Gaussian mixture models. Our proposal, outlined in Figure 1, differs
from their research in a number of important aspects. Unlike these authors,
we derive suitably binned binary data, which we describe in Section 3, in-
stead of working with the raw or intensity data. Following [Koch (2013),
Chapter 6], who demonstrates the success of using such binary data in find-
ing biologically meaningful tissue clusters, we apply k-means clustering to
the binary data. Analysis of the binary data has the added advantage of
being computationally more efficient. Furthermore, parallel computation is
possible for all steps in the approach we propose. Our approach combines
clustering with explicit feature extraction conceptually similar to the ap-
proach of Jones et al. (2011), although based on a different principle—our
Difference in Proportions of Occurrence (DIPPS) statistic which ranks and
selects the “best” variables in a data-driven way. Our use of binary data al-
lows the feature extraction results to be visualized as a single heat map with
a natural interpretation. The ability to visualize the selected features as a
single easily interpretable image has not been a part of the above-mentioned
papers and gives a significant advantage to our approach.
This paper is organized in the following way. We briefly describe relevant
background on proteomics in Section 2, and discuss advantages of MALDI-
IMS for the biological research fields. We describe MALDI-IMS data and
how to derive the binned binary data in Section 3. Section 4 covers the spa-
tial smoothing and clustering steps of our method. The DIPPS approach
(including a feature extraction step) is described in Section 5. Finally, in
Section 6 we apply our combined cluster and DIPPS approach in order to
compare several patients by considering several datasets. The results dis-
cussed in Section 6 allow us to demonstrate how these data could be used to
address biologically relevant questions such as the identification of potential
tissue-specific protein markers and classification of patients based on their
response to treatment.
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Fig. 1. Data processing workflow for our proposed combined clustering-DIPPS approach.
The background arrows (in light grey) represent parallel workflows for the three sections
from each of the three patients, each leading to a “list of tumor specific masses.” In the
final step the lists are compared as described in Section 6.
2. Proteomics background. Ovarian cancers are virtually asymptomatic
and, as a result, the vast majority of cases are detected when the disease has
metastasized. For these patients, radical surgery and chemotherapy are often
insufficient to address the disease adequately and many patients relapse.
The combination of late-stage diagnosis and unsuccessful treatments makes
ovarian cancer the most lethal gynecological cancer, with advanced stage
patients exhibiting a five year survival rate of less than 30% [Ricciardelli
and Oehler (2009), Jemal et al. (2011)]. The keys to addressing ovarian
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cancer will be as follows: increasing our understanding of the mechanisms
driving cancer progression, identifying molecular markers which can predict
treatment success and identifying new treatment targets. As proteins are key
functional components of cells and tissues, determining protein distributions
in cancer tissue represents a crucial step in addressing these key aims.
Proteins are synthesized within cells as linear amino acid sequences and
folded into more complex 3D structures that determine function and in-
tracellular location. The complete set of proteins which exist in a given
cell, tissue or biological fluid, under defined conditions, is termed its pro-
teome [Wilkins et al. (1996)]. Proteomes vary considerably between differ-
ent cellular states and understanding these variations allows insight into the
development and progression of cancer. Proteomics characterizes proteome
changes using a combination of fractionation, identification and quantita-
tion strategies. Proteomics will use either a top-down or bottom-up ap-
proach. Top-down approaches analyze intact proteins, whereas bottom-up
approaches use proteolytic enzymes (e.g., trypsin) to digest proteins into
peptides prior to analysis. The data we present is on tryptic peptides, so
our discussion is in the context of a bottom-up approach. Proteome frac-
tionation can be achieved using gel electrophoresis [Gygi et al. (2000)] or
liquid chromatography (LC), with LC being the predominant fractionation
technique [Rogowska-Wrzesinska et al. (2013)]. LC makes use of columns
to affinity-bind molecules to a stationary phase. The molecules are subse-
quently eluted over time with a changing gradient of mobile phase solvent.
In a bottom-up LC experiment peptides in a hydrophilic mobile phase are
bound to a hydrophobic stationary phase. The peptides are eluted using an
increase in the percentage of hydrophobic solvent in the mobile phase. To
characterize the fractioned peptides, the LC eluant is often directly coupled
to an MS instrument (LC-MS).
MS instruments contain an ion source, mass analyzer and detector. So-
called “soft” ionization sources such as electrospray ionization (ESI) and
matrix-assisted laser desorption/ionization (MALDI) are favored in pro-
teomics, as they prevent significant molecular fragmentation during ioniza-
tion. LC-MS instruments usually employ ESI to produce gaseous ions for
mass analysis. The mass-to-charge ratio (m/z) of these ions is measured by
the mass analyzer and detector to produce a mass spectrum of measured
intensity as a function of m/z. Peptides analyzed by LC-MS can be frag-
mented to produce spectra which correspond to amino acid composition.
Identification of these spectra is attempted using search algorithms, such
as MASCOT [see Koenig et al. (2008) and references therein], which match
measured spectra to expected fragmentation spectra. The combination of
LC-MS with bottom-up strategies is what allows proteomic studies to iden-
tify and quantify thousands of unique proteins in a given biological sample.
LC-MS suffers from two method-specific limitations:
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Fig. 2. Left, (a) shows the H&E stained tissue section, arrows indicate the four cancer
nodules. Right, (b) shows pixels plotted in their relative spatial locations, color identifies
the cluster membership produced by 4-means clustering of the binary spatially smoothed
data.
1. Tissue samples are homogenized and solubilized, which removes all
spatial information inherent in the tissue, and
2. An LC-MS run usually takes more than an hour, precluding the rapid
(≤1 day) analysis of large sample numbers (≥20).
Given that tissues are a mix of different cell populations and their orga-
nization is directly related to their functions, point 1 above can be crucial.
Typically, tissue structure is visualized by a pathologist using histological
stains such as haematoxylin and eosin (H&E) followed by light microscopy,
as shown in Figure 2(a). Such histological stains allow visualization of the
spatial distribution of cellular morphology and can provide an understand-
ing of the way in which the cellular morphology relates to cancer behavior
and, ultimately, the cancer’s effect on the patient. The spatial information is
essential in these histological stains, and it is reasonable to assume it would
be equally crucial in mass spectrometry. The loss of spatial information that
occurs during sample preparation for LC-MS analysis therefore motivated
the development of direct tissue analysis using MALDI-IMS [Cornett et al.
(2007), Groseclose et al. (2008), Gustafsson et al. (2011)]. To prepare a sam-
ple for MALDI-IMS, a tissue block is thinly sectioned (2–10 µm thick slices)
and mounted onto conductive microscopy slides. For analysis of peptides,
the tissue section is coated with a homogeneous layer of proteolytic enzyme
to digest endogenous proteins. The digest is then overlaid with a matrix
compound which co-crystallizes with the tissue-derived peptides. A MALDI
source is used to ionize these peptides directly from the tissue and facilitate
the collection of a mass spectrum from each (x, y) position on a regular grid
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across the tissue section. An acquisition spacing of 20–250 µm is typical
and balances the requirements for high quality MS data, practical data size
and measurement time. In the datasets presented here, we used a spacing
of 100 µm. The availability of spatial information in MALDI-IMS offers a
unique perspective on tissue analysis, which is complementary to LC-MS.
In this context, the advantages of MALDI-IMS are as follows:
1. Hundreds of biological molecules can be measured in a single experi-
ment in an untargeted manner, as compared to immunohistochemistry.
2. Tissue sections can be H&E stained post-acquisition of MALDI-IMS
data [Deutskens, Yang and Caprioli (2011)] and spatial changes in protein
abundance measured by MALDI-IMS can be compared to the histology
visible in the H&E stain of the same tissue (see Figure 2). This makes the
technique compatible with pathology.
3. MALDI-IMS provides a capacity for rapid interrogation of large sample
numbers. This can be achieved using tissue microarrays (TMAs) [see Grose-
close et al. (2008), Steurer et al. (2013)]; construction of TMAs involves the
extraction of cylindrical cores from multiple tissue blocks and arrangement
of these cores within a new block. A one-day sample preparation of sections
from such a block allows an overnight MALDI-IMS experiment to collect
data for ≥50 samples.
A caveat of MALDI-IMS analyses is that the proteome cannot be frac-
tionated, and the masses measured using MALDI-IMS are not fragmented
to provide sequence information. LC-MS based proteomics is required in or-
der to infer parent proteins, as in Table 1. MALDI-IMS, however, places this
information in a structural context and is therefore a crucial link between
molecular composition and morphology.
MALDI-IMS therefore provides unprecedented capacities for both pro-
teomics and pathology and, as a consequence, has important implications
Table 1
Selection of peptide m/z values, the DIPPS score of the m/z bins containing them, and
their inferred parent proteins. Peptide sequences and parent proteins were inferred by
mass matching to concurrent LC-MS/MS analyses and validated by both in situ
MALDI-MS/MS and immunohistochemistry as shown in Supplement A [Winderbaum
et al. (2015a)]
LC-MS/MS DIPPS UniProtKB/SwissProt Protein
mass [M+H]+ statistic entry name name
1628.8015 0.662 ROA1 HUMAN Heterogeneous nuclear
ribonucleoprotein A1
2854.3884 0.910 K1C18 HUMAN Keratin 18
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for research into human cancers [Gorzolka and Walch (2014)]. For exam-
ple, ovarian cancers are known to be quite heterogeneous tissues [Deininger
et al. (2008)]. Spatial analysis by MALDI-IMS allows this heterogeneity to
be addressed explicitly [Gorzolka and Walch (2014)]. Furthermore, if TMAs
are used, hundreds of patients can potentially be analyzed in a single day.
MALDI-IMS provides the opportunity to (i) screen preprepared cancer sam-
ples rapidly, targeting regions of interest and, (ii) employ complementary
LC-MS methods to characterize the tumor proteome of these tissues.
To exploit these capabilities in the future, it will be crucial to understand
and distinguish differences between patients. As proof of the concept, in this
paper we take data including multiple tissue types (e.g., tumor, adipose,
connective) from full sections of tissue from each of three patients, and
consider the problem of separating tumor-specific masses.
3. The data and binary binning. In Section 6 we consider a selection of
datasets from three surgically excised ovarian cancers, each from a different
patient; see Gustafsson (2012). An overview for our data analysis workflow
is described in Figure 1. Thin cross-sections of tissue are obtained from each
cancer, and MALDI-IMS data are collected using a Bruker Ultraflex III and
a m/z range of 1000–4500. Multiple sections are taken from each cancer,
and we refer to the data collected from each section as a “dataset.” Initially,
we consider a single typical dataset (shown in Figure 2) and will refer to it
as the “motivating dataset” throughout. A typical dataset might have 5000–
100,000 spectra, the motivating dataset consists of 13,916. The motivating
dataset will serve to illustrate our proposed method which we describe in
Sections 4 and 5, completing the workflow illustrated in Figure 1. In Section 6
we consider the remaining datasets (represented by grey background arrows
in Figure 1 and including the motivating dataset), three from each cancer,
and compare datasets within and between patients. Although we have access
to more datasets, we show only nine, as these suffice for comparisons both
within and between patients while still illustrating our method concisely.
As discussed in Section 2, each dataset contains mass spectra collected
at regularly spaced points on the surface of a thin tissue section. Each mass
spectrum has annotation meta-data corresponding to the spatial (x, y) coor-
dinates of its acquisition. The mass spectrum itself is a set of ion-intensity,
m/z value pairs, and can be thought of as a discrete approximation of ion-
intensity as a function of m/z. We will not explicitly address this functional
aspect. Each mass spectrum typically contains between 5 and 200 intensity-
peaks (local maxima), each corresponding to the m/z of a biological ana-
lyte such as a peptide or endogenous protein. A number of preprocessing
steps are involved in extracting the peaks; we use methods available in pro-
prietary software (flexAnalysis, Bruker Daltonik, http://www.bruker.com):
smoothing (Gaussian kernels), baseline reduction (TopHat), and, finally,
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peak-picking (SNAP). The SNAP algorithm isolates mono-isotopic peaks
and defines significant peaks as those peaks with a signal-to-noise ratio of
two or higher. Representing the data as peak lists significantly reduces the
amount of data involved, often by as much as two orders of magnitude, and
this can be very important due to the amount of data involved (>10 GB).
We will be concerned only with these extracted peaks from here on.
Improved peak-picking is of interest for two reasons. First, peak-picking
is currently the most computationally intensive step in our workflow, tak-
ing longer than the remainder of the data analysis combined. Conveniently,
the Bruker peak-picking can be run simultaneously with the data acquisi-
tion, which typically takes 6–14 hours depending on the number of spectra
acquired. Second, the choice of peak-picking algorithm will affect all sub-
sequent data analysis and so improvements to the peak-picking algorithm
would be expected to carry through and produce improved results down-
stream. Comparing the Bruker peak-picking that we have used with other
existing methods and making improvements based on these comparisons
is important, but is beyond the scope of this paper. All the code used to
generate our results from the peaklist data is included in Supplement B
[Winderbaum et al. (2015b)], and the peaklist data itself is in Supplement C
[Winderbaum et al. (2015c)]. Software packages that implement existing
peak-peaking algorithms and other relevant analysis tools include the R
package MALDIquant (http://strimmerlab.org/software/maldiquant/), the
MATLAB bioinformatics toolbox (http://au.mathworks.com/help/bioinfo/
index.html) and Bioconductor (http://www.bioconductor.org). For other
mass-spectrometry based software resources, see http://www.ms-utils.org.
We bin the peaks by partitioning the m/z range into equal size inter-
vals or bins, and identifying each peak with the bin it belongs too. Using a
data-independent partitioning for the binning makes comparisons between
datasets straightforward. The disadvantage is that peaks detected at very
similar m/z values will be identified with different bins if a boundary hap-
pens to fall between them. In order to address this, we suggest running all
analyses in tandem with shifted bin locations and combining the results in
order to capture any analytes whose m/z is too close to a bin boundary.
Using larger bin sizes also helps limit this effect. For the sake of brevity,
we will omit the tandem analysis from the results, as it provides only a
small improvement. We call the data after binning “binned intensity data,”
as in this form the variables correspond to the intensity (height) of peaks
in particular m/z bins. We further reduce the “binned intensity data” to
“binary binned data” where the variables (m/z bins) are binary (one/zero)
valued—corresponding to presence/absence of peaks as described by Koch
(2013), Example 6.12. The number of m/z bins in the binned data will vary
depending on the choice of bin size. Our analyses are not sensitive to choice
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of bin size, provided the bin size chosen is within a reasonable range (0.05–
2 m/z). We use an intermediate bin size of 0.25 m/z, which yields 5891
(nonempty) m/z bins in the motivating dataset. The principal effect that
choice of bin size has is on the total number of m/z bins, and the number
that are removed in the dimension reducing steps of our method—smaller
bin sizes will result in more m/z bins initially, and more being removed,
larger bin sizes result in fewer m/z bins initially, and fewer being removed.
The use of the binary data has a number of advantages, including sepa-
ration of tissue types, computational efficiency, and allowing the use of the
easily interpretable DIPPS approach we describe in Section 5. Extraneous
variables such as matrix crystal morphology can have an adverse effect on
the intensity measurements by adding noise [Garden and Sweedler (2000)].
Deininger et al. (2011) attempt to address these effects by normalization of
their intensity values. One additional advantage of using the binary transfor-
mation suggested by [Koch (2013), Example 6.12] is that it circumvents the
effects of such extraneous variables by avoiding direct use of the intensity
values, and in this sense can be considered a data cleaning step. All subse-
quent analyses will concern only the binary data, as indicated in Figure 1,
and we will refer to these simply as “the data” from here on. Similarly, we
will refer to the variables in these data as “m/z bins,” as we have done in
this section.
4. Clustering spatially smoothed data. We propose a two-step method
for separating spectra into groups corresponding to tissue types: first, a
smoothing step which acts as a data cleaning and dimension reduction step,
and incorporates the spatial information from MALDI-IMS into the data.
Second, a clustering step.
4.1. Smoothing step. The spatial information available in MALDI-IMS
data can be used to clean the data and remove m/z bins that are spatially
dispersed. We incorporate this spatial information through a spatial smooth.
Let X be a d×n binary matrix; the rows of X correspond to m/z bins and
are denoted xi•, the columns of X correspond to spectra and are denoted
x•j , and the entries of X are denoted xij . These entries xij take the value
one if peaks are present, and zero if no peaks are present in the m/z bin i in
spectrum j. Let 0≤ τ < 12 be a smoothing parameter and δ ≥ 0 a distance
cutoff.
We iteratively update the values of X. Let X(k) denote the updated ma-
trix at the kth iteration. Similarly, let x
(k)
i• , x
(k)
•j and x
(k)
ij denote the rows,
columns and values of X(k), respectively. At the kth iteration, the proportion
of spectra, T
(k)
ij , in a spatial δ-neighborhood of the jth spectrum x
(k)
•j whose
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values at the ith m/z bin x
(k)
i• agree with x
(k)
ij is
T
(k)
ij =
{
(1− x(k−1)ij ) + (2x(k−1)ij − 1)
(
x
(k−1)
i• d
⊺
j − x(k−1)ij
11×nd
⊺
j − 1
)}
.(1)
This proportion determines if the value x
(k)
ij should be changed. In (1), dj
denotes a 1× n indicator vector with entry 1 if the corresponding indexed
spectrum is in a δ-neighborhood of x•j and zero otherwise. If this proportion
T
(k)
ij is less than τ , we update the value x
(k)
ij as in (2).
We generate the smoothed data by iteratively calculating the entries of
X
(k):
x
(k)
ij =
{
x
(k−1)
ij , if T
(k)
ij > τ ,
1− x(k−1)ij , if T (k)ij ≤ τ ,
(2)
for k = 1,2, . . . , starting with X(0) =X. We stop when convergence is reached,
that is, when k = k∗ =min{k : X(k) =X(k−1)}. The spatially smoothed data
are X(k
∗).
Remarks on the smoothing process:
1. Without loss of generality, we let the distance between adjacent pixels
be one. We choose δ =
√
2 which results in a range 1 Moore neighborhood ;
see Gray (2003). This neighborhood is used in the cellular automata litera-
ture including Gardner (1970). It is worth noting that acquiring the range
1 Moore neighborhood by using the Euclidean distance and δ =
√
2 on a
regular grid is equivalent to using the Tchebychev distance, and δ = 1.
2. The smoothing parameter τ defines the proportion of neighboring spec-
tra needed to agree in order for a particular value to remain unchanged at
any given step. Small values of τ smooth less (τ = 0 leaves the data unmod-
ified), while larger values smooth more. Results will not significantly change
if τ is within the same 18 -wide interval, as changing τ within these intervals
will affect spectra only on the boundary of the acquisition region (spectra
with less than 8 neighbors). The limit τ → 12 results in maximum smoothing
and is equivalent to the intuitive median smooth. In practice, the median
smooth tends to yield over-smoothed data and often fails to converge. We
chose an intermediate smoothing parameter, τ = 14 , for these analyses. The
values 18 and
3
8 could also be used, for less or more smoothing, respectively.
3. Alternative smoothing options include kernel methods [Wand and Jones
(1995)] which apply to continuous data. These methods produce continuous
values when applied to binary data, for which there is no clear interpretation.
Our method produces binary smoothed data, maintaining the interpretabil-
ity of the binary values.
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4. At each smoothing iteration k, m/z bins are smoothed independently,
and within each m/z bin all observations are smoothed simultaneously at
each step. This means that it is possible to parallelize the smoothing algo-
rithm, making efficient use of computational resources.
5. Our smoothing step plays a similar role in our approach to the com-
bined two-step method of Alexandrov and Bartels (2013). Alexandrov and
Bartels (2013) use first an edge-preserving smooth [Tomasi and Manduchi
(1998)] and then a measure of spatial chaos to remove spatially chaotic im-
ages. Our method also removes spatially chaotic images by reducing them
to empty. Improvements could potentially be achieved by combining the two
approaches.
Bins that exhibit occurrence of peaks in a small number of spatially de-
localized spectra or in almost all spectra constitute a large proportion of all
m/z bins. These bins tend not to be relevant, as they are usually internal
calibrants [Gustafsson et al. (2012)], errors, contaminants or tissue regions
that are too small to be of interest due to the spatial (lateral) resolution used
(100 µm). This last point could be improved by using a finer lateral resolu-
tion, as discussed by Schober et al. (2012). In these data, however, biological
structures which are the same size as or smaller than the acquisition reso-
lution, in this case 100 µm, will be removed by the smoothing. These m/z
bins have zero variance after the smoothing step. Following the smoothing,
these zero-variance m/z bins are removed, reducing the dimension of the
data. The motivating dataset has 5891 m/z bins before the smoothing step.
After the smoothing step 1022 of these m/z bins have nonzero variance and
the remainder are discarded.
4.2. Clustering step. The second step in our approach concerns cluster-
ing of the spatially smoothed data. We use k-means clustering. Based on the
information available from the histology, there are three broad tissue types
present which could be labeled as fatty, connective and cancer tissue, re-
spectively. Further, there are spectra that were acquired off-tissue. Thus, we
perform k-means clustering with k = 4. We choose initial cluster centers at
random from the sample, repeat this process 100 times and choose the clus-
tering with minimum within-cluster sum of spectra-to-centroid distances.
k-means clustering of the binned intensity data with the default Euclidean
distance does not lead to interpretable or spatially localized clusters [Koch
(2013), Example 6.12]. In contrast, k-means clustering of the binned inten-
sity data with the cosine distance, and of the binary data with the Euclidean
or cosine distance, leads to clusters that correspond to the different tissue
regions. Since there is no clear superiority of one distance over the other for
the binary data, we continue with only the cosine distance, which has the
added advantage of having become an established measure of closeness for
FEATURE EXTRACTION FOR IMS 13
high-dimensional data and associated consistency results [see Koch (2013),
Sections 2.7, 13.3 and 13.4, and references therein].
For data with associated spatial information (such as MALDI-IMS data),
it is natural to display the cluster membership in the form of cluster maps
or cluster images: colored pixels at the (x, y) coordinates of the spectra
which show the cluster membership of each spectrum using different col-
ors to identify clusters. The H&E stained tissue cross-section and result of
4-means cluster analysis (by cosine distance) of the motivating dataset are
shown in Figure 2(a) and (b), respectively. The cluster membership in Fig-
ure 2(b) corresponds well with tissue types as determined by the histology
in Figure 2(a): cyan corresponds to fatty tissue, green to cancer-associated
connective tissue and orange to four cancer nodules [indicated by arrows
in Figure 2(a)]. The fourth cluster in pink corresponds well with off-tissue
spectra, apart from a small amount of “bleed-out” from the cyan cluster
possibly caused by nonspecific or “leakage” analytes. The correspondence
between cluster results and histology demonstrates that the spatial smooth
and cluster analysis isolate key molecular information which allows differen-
tiation of tissue types by their mass spectra.
This correspondence between cluster results and histology, particularly
for the cancer tissue-type, is important for the interpretation of results that
follow, and so we took extra steps to validate its accuracy. A pathologist
annotated the H&E stained tissue section for the motivating dataset [shown
in Figure 2(a)], indicating regions of cancerous tissue. In order to avoid
ambiguity in annotation, we then created an annotation subset identifying
spectra whose origin is unambiguously cancerous tissue (omitting spectra
from tissue regions of mixed tissue types, or tissue of ambiguous type). This
allows us to be confident that spectra in this annotation subset are definitely
from cancerous tissue, giving us a diagnostic measure of accuracy for our
cancer cluster. The annotation subset we obtained for the motivating dataset
contained 515 spectra, 499 (97%) of which where also contained in the 778
spectra of the orange cancer cluster of Figure 2(b).
5. The difference in proportions of occurrence (DIPPS) approach. In
Section 4 we mention the good agreement between tissue types visible in
the histology of Figure 2(a) and clusters of Figure 2(b). From the biological
perspective it is of great interest to be able to quantify the differences be-
tween these tissue types in an easily interpretable way. At a mathematical
level, a characterization of the differences between the tissue types trans-
lates into an identification of m/z bins that discriminate them. We propose
the DIPPS approach for identifying discriminating m/z bins. Other meth-
ods for determining m/z values exist in the supervised learning literature,
for example, support vector machines and PCA-based linear discriminant
analysis. A comprehensive comparison of the DIPPS approach with these
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methods in determining the “best” and “correct number” of discriminat-
ing m/z values is needed, but such a comparison is beyond the scope of
this paper. Instead we restrict attention to the new DIPPS approach which
we first explain for an arbitrary subset of binary data, and then apply to
the motivating dataset using spectra from the cancer cluster as the subset
of interest, as distinguishing these spectra from the noncancer spectra is
particularly important.
We define the DIPPS statistic for a fixed subset of data in (3), and show
how this new statistic introduces a ranking of the m/z bins based on their
ability to characterize the subset of interest. This DIPPS statistic leads to
a natural heuristic, introduced in (4), for selecting a number of the ranked
m/z bins, which we call DIPPS features, that “best” characterize the sub-
set of interest. The extraction of these DIPPS features can be interpreted
as a dimension reduction step. For data with spatial meta-data, such as
MALDI-IMS data, we propose a way of displaying graphically the informa-
tion obtained from the statistic in an easily interpretable summary image.
These maps make this technique useful in exploratory analyses, as combining
the DIPPS features into a single interpretable image allows for broad con-
clusions to be drawn quickly and easily. When the amount of data becomes
large, the approach commonly used in proteomics, namely, of considering
each m/z bin individually, is of limited use and the ability to produce a
single image that summarizes many m/z bins becomes particularly useful.
Let S be a subset of observations (columns) of the data, X. We let p(S)
denote the mean of the observations in S and, similarly, let p(Sc) denote
the mean of the observations in its compliment Sc. As the data are binary,
the kth entry of the vector p(S) is the proportion of observations in S that
take the value one for the kth m/z bin. The interpretation of binary data as
the occurrence of an event—here existence of peaks—allows the mean p(S)
to be interpreted as the proportions of occurrence (for each m/z bin) in S .
Considering occurrence (presence of peaks) in each m/z bin as a predictor of
which spectra should be in S allows us to interpret the corresponding entry
of p(S) as the “sensitivity” or true positive rate of this prediction. Similarly,
each entry of the vector 1d×1 − p(Sc) is the proportion of observations in
Sc that take the value zero for the corresponding m/z bin, and, from the
perspective of treating each m/z bin as a predictor for which spectra should
be in S , can be considered the “specificity” or true negative rate. In order
to characterize S , both sensitivity and specificity should be high. We sum
these measures of sensitivity and specificity, and subtract one to give a range
of [−1,1] and define the vector of DIPPS statistics d for S as
d(S) = p(S)−p(Sc).(3)
For convenience of notation we omit the dependence on S , and write d(S) =
d. We will similarly omit the S dependence for ta, na, c and a∗ below, as
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we are treating S as fixed. We use the entries of the vector d to rank the
m/z bins: the entry with the greatest value corresponds to the m/z bin that
characterizes S best.
Next we determine the set of m/z bins that collectively best characterize
S , that is, the DIPPS features. We do this by finding a cutoff value in a
data-driven way as follows. For a > 0 let ta be the d× 1 vector that takes
the value one if the corresponding element of d is ≥ a, and takes the value
zero otherwise. Let na be the number of entries in the vector ta equal to one.
Let c be the centroid of S . For the cosine distance, D, this is the average of
the normalized (to length one) vectors. We use the cutoff
a∗ = argmin
a
{D(c, ta)}.(4)
ta is a binary “template” vector for representing observations in S . The
centroid c represents the “center” of observations in S . In (4) we choose a∗
such that ta∗ is as close to c as possible. The na∗ DIPPS features are the
m/z bins whose corresponding entry in ta∗ is one.
In the motivating dataset we are interested in characterizing the cancer
spectra, and thus we choose S to be the set of spectra belonging to the
orange cluster shown in Figure 2(b). The cutoff of (4) is a∗ = 0.126 and
results in na∗ = 70 DIPPS features being selected from the 1022 m/z bins
remaining after smoothing. For each spectrum x•j , the sum of the DIPPS
features t⊺a∗x•j , can be visualized spatially in a “DIPPS map,” as shown in
Figure 3(b). We construct the DIPPS map pointwise at each (x, y) location.
The value of the DIPPS map at each (x, y) location, or pixel, represents
the number of DIPPS features exhibiting occurrence for the spectrum at
(x, y). These counts are visualized in heat colours: cold (blue) indicating
spectra in which none of the selected ‘DIPPS feature’ m/z bins contain
peaks, hot (red) indicating spectra in which all ‘DIPPS feature’ m/z bins
contain peaks. The ability to visualize results in a DIPPS map, which is easy
to interpret, is attractive, as considering so many m/z bins individually can
be time consuming and fail to provide a “big-picture” perspective.
The 70 DIPPS features characterize the cancer tissue, and thus deserve
inspection. Follow-up analysis can be done to identify the peptides that these
m/z bins correspond to, and to draw inference as to their parent proteins.
To illustrate the biological significance of these m/z bins, we compared their
m/z values to the previously published results of Gustafsson (2012). Two of
the highly rankedm/z bins (listed in Table 1, along with inferred parent pro-
teins) were previously identified as highly expressed in cancer by manual as-
sessment of spatial distributions. The identifications were achieved through
both mass matching to LC-MS/MS as well as in situ MS/MS [Gustafsson
(2012)]. The identity and histological distribution of these analytes (corre-
sponding to m/z bins in our data) were successfully validated using im-
munohistochemistry (see Supplement A [Winderbaum et al. (2015a)]). This
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Fig. 3. H&E stained tissue section (a) and DIPPS map (b) for the cancer cluster of the
motivating dataset. The DIPPS map shows the sum of the na∗ = 70 m/z bins with DIPPS
score greater than a∗ = 0.126. The legend relates the counts in heat colours: cold (blue)
indicating spectra in which none of the selected ‘DIPPS feature’ m/z bins contain peaks,
hot (red) indicating spectra in which all “DIPPS feature” m/z bins contain peaks. . . .
confirms that the DIPPS approach can find features of known importance.
Crucially, the DIPPS approach produces a list of characterizing m/z bins
more rapidly and comprehensively than manual inspection of individualm/z
bins.
A DIPPS map such as that shown in Figure 3(b) has an intuitive interpre-
tation that the results of cluster analysis do not. The DIPPS map highlights
gradations which reveal finer detail than is possible in cluster maps. We dis-
cuss this point further in Section 6. This visualization using DIPPS maps
becomes increasingly important in exploratory analyses when the number of
patients and datasets increases, as it quickly becomes infeasible to consider
each of the selected m/z bins individually. The DIPPS approach also allows
m/z bins crucial to cluster/tissue differentiation to be isolated and sum-
marized. This selection of DIPPS features inherent in the DIPPS approach
can also be thought of as a variable reduction step by reducing the data to
70 m/z bins. More importantly, it successfully separates tissue type-specific
m/z bins, addressing the heterogeneity of the tissue. This facilitates the
comparison of datasets, which is the focus of Section 6.
6. Application to multiple datasets. In this section we consider nine
datasets, including the motivating dataset. Of these datasets, three are from
each of three different patients which we will refer to as patients A, B and
C, respectively. We will refer to the three datasets from patient A as A1, A2
and A3, and similarly for the datasets from patients B and C. Dataset A1
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is the motivating dataset. Each of the three datasets arising from the same
patient is acquired from thin (6 µm) tissue sections of a single surgically ex-
cised tissue. Because of this experimental setup, we expect the cluster and
DIPPS maps of datasets from the same cancer to be similar in terms of the
location of the cancer clusters and the selected m/z bins. We aim to separate
within-patient from between-patient variability among the datasets.
The results of our analyses of the nine datasets are displayed in Figures 4,
5 and 6 for patients A, B and C, respectively. Each figure corresponds to
one patient and shows the three datasets in rows. Each row consists of an
H&E stain on the left, a cluster map in the center and a DIPPS map for the
cancer cluster on the right. The first row of Figure 4 repeats the results for
the motivating dataset shown in Figures 2 and 3.
In all nine datasets, as visually judged by comparison with the H&E
stained images, the clustering results correspond well with the tissue mor-
phology. In patients B and C the connective tissue was more difficult to
separate from the fatty tissue than in patient A, and so 3-means clustering
was used instead of 4-means clustering. Disagreements between clustering
results of datasets from the same patient serve to highlight the ability of
the DIPPS maps to find and extract information in the data that is not
available in the cluster maps, in a way that is remarkably robust to the
clustering. For an example of this robustness property of the DIPPS maps,
consider Figure 6—although the cluster map for dataset C2 shows a notice-
able difference in the shape of its orange cancer cluster, the DIPPS maps
show comparatively consistent spatial distributions. Similarly, in Figure 5
datasets B1 and B3 show solid orange cancer clusters, failing to detect the
clear vertical divide shown in the H&E stains, yet this divide is still apparent
in the DIPPS maps.
The DIPPS maps are also more representative of the data, as they reveal
gradual changes and fine detail that cannot be represented by the “hard”
boundaries in a cluster map. For example, consider the bottom left region of
tissue in Figure 5. The DIPPS maps highlight (subtly) a line following the
bottom of the tissue corresponding to heterogeneous cancer-associated con-
nective tissue. This is particularly interesting, as this “partial” highlighting
in the DIPPS map indicates that there exists a subset of the selected m/z
bins that exhibit presence in this region.
In addition to producing the DIPPS maps, the DIPPS approach yields a
set of m/z bins that characterize the subset of the data in question. This
set of DIPPS features can be used to compare tissue types across several
datasets. We implement the DIPPS approach as described in Section 5 to
identify DIPPS features for the cancer cluster in each of the nine datasets.
To determine how similar these sets of characterizing m/z bins (DIPPS
features) are, we use the Jaccard distance [Jaccard (1901)]. For a pair of
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Fig. 4. H&E stains (left column), cluster maps (center column), and DIPPS maps for
the cancer cluster (right column) for the three datasets A1, A2, and A3 (each represented
in a row). Note that na∗ = 70,45,61 m/z bins are visualized in the DIPPS maps for the
datasets A1, A2, and A3, respectively.
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Fig. 5. H&E stains (left column), cluster maps (center column), and DIPPS maps for
the cancer cluster (right column) for the three datasets B1, B2, and B3 (each represented
in a row). Note that na∗ = 173,117,111 m/z bins are visualized in the DIPPS maps for
the datasets B1, B2, and B3, respectively.
sets Si, Sj , the Jaccard distance is
J(Si, Sj) = 1− |Si ∩ Sj||Si ∪ Sj| .(5)
Figure 7 shows the pairwise Jaccard distances between the DIPPS features
characterizing cancer. The “colors” range from darkest for a Jaccard distance
of zero (indicating equality of sets) to white for a Jaccard distance of one,
which indicates disjoint sets.
The block diagonal of Figure 7 is notably dark—this illustrates that dif-
ferences within patients are smaller than differences between patients. This
difference allows DIPPS features common to a particular patient to be
separated from features that characterize cancer across multiple patients.
Dataset C3 is an exception to this trend, as it shows notably less similarity
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Fig. 6. H&E stains (left column), cluster maps (center column), and DIPPS maps for
the cancer cluster (right column) for the three datasets C1, C2, and C3 (each represented
in a row). Note that na∗ = 74,38,17 m/z bins are visualized in the DIPPS maps for the
datasets C1, C2, and C3, respectively.
to other datasets across the board (both within patient C and to datasets
from other patients). Further inquiry into the raw data acquisition reveals
that there was likely some problem at the sample preparation step for this
slide, possibly in either the digestion or matrix deposition, as fewer peaks
are observed from spectra in dataset C3 in general when compared to typical
spectra from any of the other datasets. In this way, our proposed exploratory
analyses are also capable of alerting quality control issues, which would not
have been obvious from the clustering results alone.
There are a number of DIPPS features common to all 3 patients, includ-
ing the m/z bin centered at 1628.75, mentioned in Section 5. The peptide
sequence and inferred parent protein of this feature (listed in Table 1) have
been validated by in situ MS/MS and immunohistochemistry (shown in Sup-
plement A [Winderbaum et al. (2015a)]), respectively, indicating that the
protein from which this peptide derives is highly expressed in the cancer
tissue of these patients. This protein could therefore be investigated further
as a marker for ovarian cancer in a larger patient cohort.
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Fig. 7. The 9 × 9 grid shows pairwise Jaccard distances between the sets of m/z bins
characterizing the cancer clusters. Rows (and columns) correspond to the 9 datasets. The
color of each pixel indicates the value of the Jaccard distance—white corresponding to a
value of one, black to zero.
Patient specific DIPPS features could be further investigated for their
ability to classify cancers according to clinical or diagnostic criteria such as
response to treatment. There appears to be a difference between patients
A/C and B, as can be seen in Figure 7. This difference could be a conse-
quence of the relatively larger number of DIPPS features identified in patient
B datasets. The discrepancy in the number of selected m/z bins between
patients A/C and B could be explained by the large amount of necrotic tis-
sue in the patient B sample. Mass spectra from necrotic tissue are expected
to be vastly different from those of other cancer tissue, which would indicate
that the patient-specific m/z bins in patient B are likely to be markers for
necrotic tissue.
Other tissue types could be considered (fatty and connective tissues), and
a figure similar to Figure 7 could be produced for each of them. Such figures
do not show a notably darker block-diagonal in the way that Figure 7 does.
This tells us that the main differences between patients are in the patients’
cancer, rather than in their other tissues, and reinforces how crucial it is
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to address the heterogeneity of these data by separating tissue types before
conducting comparisons between patients.
7. Conclusion. This paper proposes an integrated approach to cluster-
ing and feature extraction for spatially distributed high-dimensional data.
This approach is based on our difference in proportions (DIPPS) statistic
and includes novel visualizations which enhance the cluster maps. For the
MALDI-IMS cancer data, these maps have a natural interpretation in terms
of the features that characterize cancer tissue. Application of our approach
to different datasets from a number of patients allowed us to differentiate
within-patient variability from between-patient variability.
In proteomics, the ability to automate feature extraction and to present
these features as DIPPS maps provides an opportunity for holistic appraisal
of MALDI-IMS data. This is crucial due to the size and number of such
datasets and their high-dimensional nature. By isolating features important
to specific tissue types and reporting similarities across patients, it will be
easier to identify m/z bins for further validation as tissue markers and to
build models for addressing clinical questions such as predicting chemother-
apy response and patient survival.
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SUPPLEMENTARY MATERIAL
Supplement A: Immunihistochemical Validation
(DOI: 10.1214/15-AOAS870SUPPA; .zip). Optical images of immunohisto-
chemical (IHC) tissue stains, validating three proteins as cancer-specific,
including the two inferred parent proteins of Table 1. Top row are patient
A replicates, bottom row patient C replicates.
Supplement B: Source Code (DOI: 10.1214/15-AOAS870SUPPB; .zip).
Source code including cache and intermediate data files capable of reproduc-
ing all analyses up to and including compiling this document. Computations
where done in MATLAB, and results compiled in LATEX using the R package
knitr.
Supplement C: Peaklist Data (DOI: 10.1214/15-AOAS870SUPPC; .zip).
Raw peaklist data, used to generate the intermediate data files in Supple-
ment B [Winderbaum et al. (2015b)].
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